Uncategorized

Seaport, Hemab price IPOs, while Avalyn soars in Nasdaq debut

Published

4 hours ago

on

A trio of biotechs priced their IPOs on Thursday into Friday morning, setting the stage for their public trading debuts with more than $850 million combined.

Seaport Therapeutics, Hemab Therapeutics and Avalyn Pharma are the …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version